{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:19Z","timestamp":1793119639129,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>This study examined the effect of metformin use on the prognosis of gastric cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>The study population comprised 2187 patients who underwent curative gastrectomy for the treatment of gastric cancer. They were divided into 3 groups: metformin (n=103), non-metformin (n=139), and non-diabetes mellitus (DM) (n=1945) according to their history of type 2 DM and metformin use. Survival, disease recurrence, and the pathologic stage were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall survival was better in the metformin group than in the non-DM group (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.005). Metformin use was an independent prognostic factor of overall survival, cancer recurrence, and peritoneal recurrence. An effect of metformin use was especially notable in patients with T4 or N0 disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Metformin improves the survival of patients with gastric cancer and type 2 DM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000627","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:13:20Z","timestamp":1573067600000},"page":"909-917","source":"Crossref","is-referenced-by-count":17,"title":["The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus"],"prefix":"10.1097","volume":"42","author":[{"given":"Ho Seok","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Ju","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0140-6736(09)60937-5","article-title":"Diabetes in Asia","volume":"375","author":"Ramachandran","year":"2010","journal-title":"Lancet"},{"issue":"suppl 1","key":"R2-20230905","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1089\/dia.2011.0019","article-title":"Overall mortality in diabetes mellitus: where do we stand today?","volume":"13","author":"Dailey","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"R3-20230905","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20230905","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.ejca.2014.05.020","article-title":"Diabetes mellitus increases the risk of early gastric cancer development","volume":"50","author":"Sekikawa","year":"2014","journal-title":"Eur J Cancer"},{"key":"R5-20230905","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/SLA.0000000000001086","article-title":"Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy","volume":"263","author":"Lee","year":"2016","journal-title":"Ann Surg"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(14)60613-9","article-title":"Prevention and management of type 2 diabetes: dietary components and nutritional strategies","volume":"383","author":"Ley","year":"2014","journal-title":"Lancet"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-642-38007-5_21","article-title":"New perspective for an old antidiabetic drug: metformin as anticancer agent","volume":"159","author":"Leone","year":"2014","journal-title":"Cancer Treat Res"},{"key":"R8-20230905","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.18632\/oncotarget.13639","article-title":"Anti-tumor activity of metformin: from metabolic and epigenetic perspectives","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"R9-20230905","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.18632\/oncotarget.6748","article-title":"Negative regulation of Bmi-1 by AMPK and implication in cancer progression","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20230905","first-page":"4615","article-title":"The prognostic value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-enriched subtype breast cancer, a retrospective analysis","volume":"37","author":"Zhou","year":"2017","journal-title":"Anticancer Res"},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo","volume":"11","author":"Kato","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"R12-20230905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2013.45.1.1","article-title":"Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010","volume":"45","author":"Jung","year":"2013","journal-title":"Cancer Res Treat"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5230\/jgc.2017.17.e23","article-title":"Comparison of the differences in survival rates between the 7th and 8th editions of the AJCC TNM staging system for gastric adenocarcinoma: a single-institution study of 5,507 patients in Korea","volume":"17","author":"Kim","year":"2017","journal-title":"J Gastric Cancer"},{"key":"R14-20230905","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10120-014-0442-3","article-title":"Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario","volume":"19","author":"Dixon","year":"2016","journal-title":"Gastric Cancer"},{"key":"R15-20230905","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4093\/dmj.2011.35.5.431","article-title":"2011 clinical practice guidelines for type 2 diabetes in Korea","volume":"35","author":"Ko","year":"2011","journal-title":"Diabetes Metab J"},{"key":"R16-20230905","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"R17-20230905","doi-asserted-by":"crossref","first-page":"e0188904","DOI":"10.1371\/journal.pone.0188904","article-title":"A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients","volume":"12","author":"Choi","year":"2017","journal-title":"PLoS One"},{"key":"R18-20230905","first-page":"735","article-title":"A perception of the development trend of radiological T staging in gastric cancer through UICC\/AJCC 8th edition","volume":"20","author":"Tang","year":"2017","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"R19-20230905","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","article-title":"7th edition of the AJCC cancer staging manual: stomach","volume":"17","author":"Washington","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R20-20230905","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer?","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur J Cancer"},{"key":"R21-20230905","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"key":"R22-20230905","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"R23-20230905","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11523-016-0423-z","article-title":"The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development","volume":"11","author":"Gong","year":"2016","journal-title":"Target Oncol"},{"key":"R24-20230905","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1074\/jbc.271.2.611","article-title":"Mammalian AMP-activated protein kinase subfamily","volume":"271","author":"Stapleton","year":"1996","journal-title":"J Biol Chem"},{"key":"R25-20230905","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-12-0007","article-title":"Metformin in cancer: translational challenges","volume":"48","author":"Dowling","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"R26-20230905","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2016.10.004","article-title":"Incidence and predictors of type 2 diabetes among Koreans: a 12-year follow up of the Korean Genome and Epidemiology Study","volume":"123","author":"Han","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R27-20230905","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/bjs.10509","article-title":"Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan","volume":"104","author":"Tokunaga","year":"2017","journal-title":"Br J Surg"},{"key":"R28-20230905","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1158\/1940-6207.CAPR-16-0232","article-title":"Fixed-dose combinations of pioglitazone and metformin for lung cancer prevention","volume":"10","author":"Seabloom","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"R29-20230905","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1055-9965.EPI-13-0347","article-title":"A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer","volume":"22","author":"Spillane","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R30-20230905","doi-asserted-by":"crossref","first-page":"e1750","DOI":"10.1097\/MD.0000000000001750","article-title":"Extent of serosal changes predicts peritoneal recurrence and poor prognosis after curative surgery for gastric cancer","volume":"94","author":"Kang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R31-20230905","first-page":"6991","article-title":"Mechanisms of peritoneal dissemination in gastric cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"R32-20230905","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.22.9.1408","article-title":"Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes","volume":"22","author":"Golden","year":"1999","journal-title":"Diabetes Care"},{"key":"R33-20230905","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2007.05.006","article-title":"Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery","volume":"22","author":"Jones","year":"2008","journal-title":"J Diabetes Complications"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:22:25Z","timestamp":1693956145000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000627","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}